Ali Aminian
Overview
Explore the profile of Ali Aminian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
215
Citations
4851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simonson D, Gourash W, Arterburn D, Hu B, Kashyap S, Cummings D, et al.
Diabetes Care
. 2025 Feb;
PMID: 39903478
Objective: Type 2 diabetes and obesity are associated with reduced health-related quality of life (HRQoL) and health utility (HU), but long-term effects of metabolic/bariatric surgery (MBS) compared with those of...
2.
Aminian A, Aljabri A, Wang S, Bena J, Allende D, Rosen H, et al.
Nat Med
. 2025 Jan;
PMID: 39870816
No therapy has been shown to reduce the risk of major adverse liver outcomes (MALO) in patients with cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH). The Surgical Procedures Eliminate Compensated...
3.
De Luca M, Shikora S, Eisenberg D, Angrisani L, Parmar C, Alqahtani A, et al.
Surg Obes Relat Dis
. 2024 Oct;
20(11):991-1025.
PMID: 39419572
The 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) updated the indications for metabolic and bariatric surgery...
4.
Wills M, Alavi M, Aleassa E, Tu C, Wilson R, Corcelles R, et al.
Surg Endosc
. 2024 Oct;
39(1):425-431.
PMID: 39365468
Introduction: Obesity is a major risk factor for idiopathic intracranial hypertension (IIH). Effective therapeutics for preventing disease progression and alleviating symptoms are limited. This study aims to examine the effects...
5.
Gross A, Gentle C, Wehrle C, Nimylowycz K, Said Al-Deen S, Aminian A, et al.
Surgery
. 2024 Sep;
179:108806.
PMID: 39332938
Objective: Study findings showing an association between nonsteroidal anti-inflammatory drug use and marginal ulcer, a significant cause of morbidity after gastrojejunostomy, have been inconsistent. This study aimed to evaluate this...
6.
De Luca M, Shikora S, Eisenberg D, Angrisani L, Parmar C, Alqahtani A, et al.
Obes Surg
. 2024 Sep;
34(11):3963-4096.
PMID: 39320627
The 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) updated the indications for Metabolic and Bariatric Surgery...
7.
Lundholm M, Kirschling S, Hu B, Aminian A, Arterburn D, Courcoulas A, et al.
Diabetes Obes Metab
. 2024 Sep;
26(12):6055-6061.
PMID: 39267261
No abstract available.
8.
Wilkerson A, Gentle C, Dewey E, Sajankila N, Buchalter R, Strong A, et al.
Surg Endosc
. 2024 Aug;
38(11):6827-6838.
PMID: 39168860
Background: Food insecurity has been linked to higher rates of obesity. It has also been shown to diminish the effectiveness of weight loss strategies, including intensive lifestyle interventions. One essential...
9.
Kermansaravi M, Chiappetta S, Shikora S, Musella M, Kow L, Aarts E, et al.
Obes Surg
. 2024 Jul;
34(9):3216-3228.
PMID: 39046625
Purpose: With the global epidemic of obesity, the importance of metabolic and bariatric surgery (MBS) is greater than ever before. Performing these surgeries requires academic training and the completion of...
10.
Nasta A, Goel R, Singhal R, Lemmens L, Baig S, Seki Y, et al.
Obes Res Clin Pract
. 2024 Jul;
18(3):195-200.
PMID: 38955573
Introduction: Revisional bariatric surgery (RBS) for insufficient weight loss/weight regain or metabolic relapse is increasing worldwide. There is currently no large multinational, prospective data on 30-day morbidity and mortality of...